90 results on '"Delabar, Jean Maurice"'
Search Results
2. Corrigendum to: DYRK1A interacts with the REST/NRSF-SWI/SNF chromatin remodelling complex to deregulate gene clusters involved in the neuronal phenotypic traits of Down syndrome
3. Building the Future Therapies for Down Syndrome: The Third International Conference of the T21 Research Society
4. New perspectives on molecular and genic therapies in Down syndrome
5. Prenatal treatment with EGCG enriched green tea extract rescues GAD67 related developmental and cognitive defects in Down syndrome mouse models
6. Translating molecular advances in Down syndrome and Fragile X syndrome into therapies
7. LPS-Induced Inflammation Abolishes the Effect of DYRK1A on IkB Stability in the Brain of Mice
8. DYRK1A Is a Regulator of S-Phase Entry in Hepatic Progenitor Cells
9. GABAergic over-inhibition, a promising hypothesis for cognitive deficits in Down syndrome
10. Overexpression of the DYRK1A Gene (Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A) Induces Alterations of the Serotoninergic and Dopaminergic Processing in Murine Brain Tissues
11. Impact of Dyrk1A level on alcohol metabolism
12. Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial
13. Changing Paradigms in Down Syndrome: The First International Conference of the Trisomy 21 Research Society
14. New Perspectives for the Rescue of Cognitive Disability in Down Syndrome
15. DYRK1A BAC Transgenic Mouse: A New Model of Thyroid Dysgenesis in Down Syndrome
16. Corrective effects of hepatotoxicity by hepatic Dyrk1a gene delivery in mice with intermediate hyperhomocysteinemia
17. Excitation/inhibition balance and learning are modified by Dyrk1a gene dosage
18. Dyrk1A induces pancreatic β cell mass expansion and improves glucose tolerance
19. Molecular Rescue of DYRK1A Overexpression in Cystathionine Beta Synthase-Deficient Mouse Brain by Enriched Environment Combined with Voluntary Exercise
20. Prenatal treatment of Down syndrome
21. A high-performance liquid chromatography assay for Dyrk1a, a Down syndrome-associated kinase
22. Dyrk1a haploinsufficiency induces diabetes in mice through decreased pancreatic beta cell mass
23. One-carbon cycle alterations induced by Dyrk1a dosage
24. DYRK1A overexpression decreases plasma lecithin:cholesterol acyltransferase activity and apolipoprotein A-I levels
25. Hepatocyte-specific Dyrk1a gene transfer rescues plasma apolipoprotein A-I levels and aortic Akt/GSK3 pathways in hyperhomocysteinemic mice
26. Plasma nitrate levels are increased in adult Down syndrome patients
27. Extensive Natural Variation for Cellular Hydrogen Peroxide Release Is Genetically Controlled
28. Dyrk1A, a Serine/Threonine Kinase, is Involved in ERK and Akt Activation in the Brain of Hyperhomocysteinemic Mice
29. Molecular Signatures of Cardiac Defects in Down Syndrome Lymphoblastoid Cell Lines Suggest Altered Ciliome and Hedgehog Pathways
30. Mice Deficient in Cystathionine Beta Synthase Display Increased Dyrk1A and SAHH Activities in Brain
31. BDNF and DYRK1A Are Variable and Inversely Correlated in Lymphoblastoid Cell Lines from Down Syndrome Patients
32. Dyrk1a activates antioxidant NQO1 expression through an ERK1/2–Nrf2 dependent mechanism
33. Effect of red wine polyphenol dietary supplementation on two phase II enzymes in liver of hyperhomocysteinemic mice
34. Hyperhomocysteinemia-induced Dyrk1a downregulation results in cardiomyocyte hypertrophy in rats
35. Myocardial fibrosis and TGFB expression in hyperhomocysteinemic rats
36. DYRK1A, a Novel Determinant of the Methionine-Homocysteine Cycle in Different Mouse Models Overexpressing this Down-Syndrome-Associated Kinase
37. The 50th anniversary of the discovery of trisomy 21: The past, present, and future of research and treatment of Down syndrome
38. Effects of red wine polyphenolic compounds on paraoxonase-1 and lectin-like oxidized low-density lipoprotein receptor-1 in hyperhomocysteinemic mice
39. Calpain activation is required for homocysteine-mediated hepatic degradation of inhibitor Ikappa B alpha
40. A quantitative assessment of gene expression (QAGE) reveals differential overexpression of DOPEY2, a candidate gene for mental retardation, in Down syndrome brain regions
41. DYRK1A interacts with the REST/NRSF-SWI/SNF chromatin remodelling complex to deregulate gene clusters involved in the neuronal phenotypic traits of Down syndrome
42. Resveratrol supplementation worsen the dysregulation of genes involved in hepatic lipid homeostasis observed in hyperhomocysteinemic mice
43. Effect of hyperhomocysteinemia on the protein kinase DYRK1A in liver of mice
44. The Protein Kinase DYRK1A Regulates Caspase-9-Mediated Apoptosis during Retina Development
45. Increased Dosage ofDYRK1A and Brain Volumetric Alterations in a YAC Model of Partial Trisomy 21
46. New cerebellar phenotypes in YAC transgenic mouse in vivo library of human Down syndrome critical region-1
47. Proteomic Shifts in Embryonic Stem Cells with Gene Dose Modifications Suggest the Presence of Balancer Proteins in Protein Regulatory Networks
48. Mice lacking cystathionine beta synthase have lung fibrosis and air space enlargement
49. Dysregulation of growth factor receptor‐bound protein 2 and fascin in hippocampus of mice polytransgenic for chromosome 21 structures
50. Mice deficient in cystathionine beta synthase display altered homocysteine remethylation pathway
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.